Cargando…
Pretreatment biopsy analysis of DAB2IP identifies subpopulation of high‐risk prostate cancer patients with worse survival following radiation therapy
Decreased expression of tumor suppressor DAB2IP is linked to aggressive cancer and radiation resistance in several malignancies, but clinical survival data is largely unknown. We hypothesized that pretreatment DAB2IP reduction would predict worse prostate cancer‐specific survival (PCSS). Immunohisto...
Autores principales: | Jacobs, Corbin, Tumati, Vasu, Kapur, Payal, Yan, Jingsheng, Xie, Xian‐Jin, Hannan, Raquibul, Hsieh, Jer‐Tsong, Kim, Dong Wook Nathan, Saha, Debabrata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940806/ https://www.ncbi.nlm.nih.gov/pubmed/26471467 http://dx.doi.org/10.1002/cam4.554 |
Ejemplares similares
-
DAB2IP in cancer
por: Liu, Liang, et al.
Publicado: (2015) -
DAB2IP modulates primary cilia formation associated with renal tumorigenesis
por: Lin, Chun-Jung, et al.
Publicado: (2020) -
Validation of DAB2IP methylation and its relative significance in predicting outcome in renal cell carcinoma
por: Wang, Zong-Ren, et al.
Publicado: (2016) -
Tumor suppressor protein DAB2IP participates in chromosomal stability maintenance through activating spindle assembly checkpoint and stabilizing kinetochore-microtubule attachments
por: Yu, Lan, et al.
Publicado: (2016) -
Mitotic phosphorylation of tumor suppressor DAB2IP maintains spindle assembly checkpoint and chromosomal stability through activating PLK1-Mps1 signal pathway and stabilizing mitotic checkpoint complex
por: Yu, Lan, et al.
Publicado: (2021)